Stock Take
Ellie Donnelly: Cathal Friel’s Hvivo gives investors reason for cheer
The veteran entrepreneur is continuing his success of listing in London having ‘totally given up on’ the Irish Stock Exchange
Fans of Cathal Friel will have been cheering last week after Hvivo, the Irish pharmaceutical services company he co-founded, announced that it was initiating an annual dividend policy.
The company, which provides end-to-end early clinical development services to its growing client base, is paying a dividend for the year of around £1.4 million, which equates to 0.20p per ordinary share.
Hvivo, whose share price is currently up almost 14 per cent this year at 29.5p, ...